Description
+ Include: 23 videos + 19 pdfs, size: 4.96 GB
+ Target Audience: medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in diagnosis, treatment, and biomedical research of lymphoma
+ Sample video: contact me for sample video
+ Information:
Friday, May 14, 2021, 9:45 AM – Saturday, May 15, 2021, 12:40 PM EST
This symposium will feature updated information on lymphoma biology, diagnosis, and ongoing efforts to translate the scientific discoveries into novel treatment strategies for a variety of lymphoma subtypes. This year, we will have a particular focus on the recent treatment options developed for patients with relapsed or refractory disease. Faculty will present those and then discuss during a panel how to best approach patients’ situation. We will also cover in a special session recent advances in the biology of lymphoma and how this will translate to innovative therapeutic interventions. Participants will have the opportunity to discuss diagnostic and management cases, and how to incorporate biomarkers and imaging into clinical practice and clinical trials.
Who Should Attend
The target audience for this symposium includes medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in diagnosis, treatment, and biomedical research of lymphoma.
- provide up-to-date information on recent treatment options for patients with Hodgkin and non-Hodgkin lymphoma
- provide up-to-date information on recent updates for lymphoma imaging and pathology
- provide up-to-date information on innovative avenues for therapeutic interventions
+ Topics:
ASCT & Cellular Therapies in HL.mp4
ASCT & Cellular Therapies in HL.pdf
Can ASCT be Avoided in Relapsed HL.mp4
Can ASCT be Avoided in Relapsed HL.pdf
CAR-T in RR MCL.mp4
CAR-T in RR MCL.pdf
Connecting the Dots- The Link Between Serine Metabolism and Lymphoma Epigenetics.mp4
Connecting the Dots- The Link Between Serine Metabolism and Lymphoma Epigenetics.pdf
Diffuse Large B-cell Lymphoma (DLBCL) Panel Discussion- Q&A.mp4
DLBCL Pathology- New Insights.mp4
DLBCL Pathology- New Insights.pdf
Effective and Off the Shelf – New Agents in Relapsed and Refractory DLBCL.mp4
Effective and Off the Shelf – New Agents in Relapsed and Refractory DLBCL.pdf
Follicular Lymphoma (FL) Panel Discussion- Q&A.mp4
Hodgkin Lymphoma (HL) Panel Discussion- Q&A.mp4
Less is More- New RT Paradigm for Indolent Lymphomas.mp4
Less is More- New RT Paradigm for Indolent Lymphomas.pdf
Lessons from CD19 CAR Therapy.mp4
Lessons from CD19 CAR Therapy.pdf
Lymphoma2021_brochure.pdf
Management of Early Relapses- New Agents.mp4
Management of Early Relapses- New Agents.pdf
Managing Early Relapses in FL- The Role of Chemotherapy.mp4
Managing Early Relapses in FL- The Role of Chemotherapy.pdf
Mantle Cell Lymphoma Panel Discussion- Q&A.mp4
MCL Pathology- New Insights.mp4
MCL Pathology- New Insights.pdf
Mechanisms of B-cell Selection as Therapeutic Targets in Pre-GC Lymphomas.mp4
Mechanisms of B-cell Selection as Therapeutic Targets in Pre-GC Lymphomas.pdf
Metabolic and Epigenetic Cooperativity in T Cell Lymphoma.mp4
Metabolic and Epigenetic Cooperativity in T Cell Lymphoma.pdf
New Vulnerabilities in T-cell Lymphomas.mp4
New Vulnerabilities in T-cell Lymphomas.pdf
PET-CT in HL- Recent Insights.mp4
PET-CT in HL- Recent Insights.pdf
Positioning CAR-T in Relapsed Refractory DLBCL.mp4
Positioning CAR-T in Relapsed Refractory DLBCL.pdf
Starving Lymphoma Cells Panel Discussion- Q&A.mp4
Targeted Therapies in MCL.mp4
Targeted Therapies in MCL.pdf
Understanding the Role of Oxidative Metabolism in Blood Cancers.mp4
Understanding the Role of Oxidative Metabolism in Blood Cancers.pdf
Reviews
There are no reviews yet.